Jason Colgate is best known for being a versatile and dynamic leader and dealmaker in healthcare, and he enjoys both getting his hands dirty on the operating side as well as analyzing companies on the investment side. He has a passion for working with entrepreneurs and executives, for improving the state of healthcare, and also with growing teams and value at the enterprise and individual level. His role at Eli Global as Managing Director of the M&A team is to facilitate the origination and execution of acquisitions across the umbrella of 20 portfolios, which consists of over 150 independent businesses with $26B in assets. Eli Global is a holding company that focuses on buying and growing businesses, and in 2017 Eli completed 30 acquisitions. Before Eli Global, Jason had experience in private equity, corporate development, investment banking, and operating roles across the healthcare spectrum from ventures to Fortune 50 businesses to boutique investment firms, including Bourne Capital Partners, Quintiles, Johnson & Johnson Development Corporation (JJDC), and Boston Scientific. Jason received an MBA from UNC Chapel Hill as well as a B.M. for Cello Performance at Vanderbilt University under the Dinah Shore Scholarship. He is also a FINRA series 63 and 79 investment banking registered advisor and a member of the ACG. Jason likes to make a difference on various boards too such as the Charlotte Symphony Orchestra and the UNC Kenan-Flagler Business School, and he has been a frequent guest speaker at universities as well as industry conferences on healthcare and M&A.